SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-067741
Filing Date
2024-08-12
Accepted
2024-08-12 17:00:21
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210822-10q_180life.htm   iXBRL 10-Q 746746
2 CERTIFICATION ea021082201ex31-1_180life.htm EX-31.1 9904
3 CERTIFICATION ea021082201ex31-2_180life.htm EX-31.2 9761
4 CERTIFICATION ea021082201ex32-1_180life.htm EX-32.1 3385
5 CERTIFICATION ea021082201ex32-2_180life.htm EX-32.2 3448
6 GRAPHIC image_001.jpg GRAPHIC 3676
  Complete submission text file 0001213900-24-067741.txt   4698651

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20240630.xsd EX-101.SCH 50503
8 XBRL CALCULATION FILE atnf-20240630_cal.xml EX-101.CAL 32341
9 XBRL DEFINITION FILE atnf-20240630_def.xml EX-101.DEF 233857
10 XBRL LABEL FILE atnf-20240630_lab.xml EX-101.LAB 431929
11 XBRL PRESENTATION FILE atnf-20240630_pre.xml EX-101.PRE 237373
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0210822-10q_180life_htm.xml XML 486356
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 241197741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)